AGRI NUTRITION GROUP LTD
NT 10-K, 1997-01-28
PHARMACEUTICAL PREPARATIONS
Previous: MEDPLUS INC /OH/, S-3, 1997-01-28
Next: IPC INFORMATION SYSTEMS INC, 10-K/A, 1997-01-28



                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                   FORM 12b-25

                           NOTIFICATION OF LATE FILING

(Check  One):[X] Form 10-K [ ]Form 20-F [ ]Form 11-K [ ]Form 10-Q 

             [ ] Form N-SAR For Period Ended: October 31, 1996
             [ ] Transition Report on Form 10-K 
             [ ] Transition Report on Form 20-F 
             [ ] Transition Report on Form 11-K 
             [ ] Transition Report on Form 10-Q 
             [ ] Transition Report on Form N-SAR
                 For the Transition Period Ended:___________________________

Read Instruction (on back page) Before Preparing Form. Please Print or Type. 
Nothing in this form shall be construed to imply that the Commission has 
verified any information contained herein.

If the notification relates to a portion of the filing checked above, identify
the Item(s) to which the notification relates:

- --------------------------------------------------------------------------------
PART 1 - REGISTRANT INFORMATION

- --------------------------------------------------------------------------------
Full Name of Registrant
Agri-Nutrition Group Limited
- --------------------------------------------------------------------------------
Former Name if Applicable

- --------------------------------------------------------------------------------
Address of Principal Executive Office (Street and Number)
Riverport Executive Center II
13801 Riverport Drive, Suite 111
- --------------------------------------------------------------------------------
City, State and Zip Code
Maryland Heights, Missouri  63043

PART II - RULES 12b-25(b) AND (c)

If the subject report could not be filed without unreasonable effort or expense
and the registrant seeks relief pursuant to Rule 12b-25(b), the following should
be completed. (Check box if appropriate)

      (a) The reasons described in reasonable detail in Part III of this form
          could not be eliminated without unreasonable effort or expense;


<PAGE>



  [X]     (b) The subject annual report, semi-annual report, transition report
          on Form 10-K, Form 20-F, 11-K, Form N-SAR, or portion thereof, will be
          filed on or before the fifteenth calendar day following the prescribed
          due date; or the subject quarterly report of transition report on Form
          10-Q, or portion thereof will be filed on or before the fifth calendar
          day following the prescribed due date; and
      (c) The accountant's statement or other exhibit required by Rule 12b-25(c)
          has been attached if applicable.

PART III - NARRATIVE

State below in reasonable detail the reasons why the Form 10-K, 11-K, 10-Q,
N-SAR, or the transition report or portion thereof, could not be filed within
the prescribed time period.
(Attach Extra Sheets if Needed)

The Registrant was unable to finalize its financial statements in a timely
manner without unreasonable effort or expense.

PART IV - OTHER INFORMATION

(1) Name and telephone number of person to contact in regard to this
    notification.

    (Name) Robert J. Elfanbaum    (Area Code) 314    (Telephone Number) 298-7330

(2) Have all other periodic reports required under Section 13 or 15(d) of the
    Securities Exchange Act of 1934 or Section 30 of the Investment Company Act
    of 1940 during the preceding 12 months (or for such shorter) period that the
    registrant was required to file such reports) been filed? If answer is no,
    identify report(s). [X] Yes [ ]No
(3) Is it anticipated that any significant change in results of operations from
    the corresponding period for the last fiscal year will be reflected by the
    earnings statements to be included in the subject report or portion thereof?
    [ ] Yes [X]No

    If so, attach an explanation of the anticipated change, both narratively,
    and quantitatively, and, if appropriate, state the reasons why a reasonable
    estimate of the results cannot be made.


- --------------------------------------------------------------------------------
(Name of Registrant as Specified in Charter) Agri-Nutrition Group Limited has
caused this notification to be signed on its behalf by the undersigned hereunto
duly authorized.



<PAGE>


Date: 1/27/97                          By:  ROBERT J. ELFANBAUM

INSTRUCTION: The form may be signed by an executive officer of the registrant or
by other duly authorized representative. The name and title of the person
signing the form shall be typed or printed beneath the signature. If the
statement is signed on behalf of the registrant by an authorized representative
(other than an executive officer), evidence of the representative's authority to
sign on behalf of the registrant shall be filed with the form.

                                ATTENTION

Intentional misstatements or omissions of fact constitute Federal Criminal 
Violations (See 18 U.S.C. 1001).

                              GENERAL INSTRUCTIONS

1. This form is required by Rule 12b-25 (17 CFR 240.12b-25) of the General Rules
   and regulations under the Securities Exchange Act of 1934.

2. One signed original and four conformed copies of this form and amendments
   thereto must be completed and filed with the Securities and Exchange
   Commission, Washington, D.C. 20549, in accordance with Rule 0-3 of the
   General Rules and Regulations under the Act. The information contained in or
   filed with the form will be made a matter of public record in the Commission
   files.

3. A manually signed copy of this form and amendments thereto shall be filed
   with each national securities exchange on which any class of securities of
   the registrant is registered.

4. Amendments to the notification must also be filed on form 12b-25, but need
   not restate information that has been correctly furnished. The form shall be
   clearly identified as an amended notification.


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission